Products

What will AGI do for Ambucaine?

This classification denotes an anesthetic agent with the molecular formula C17H28N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M7G4B57ZCB, chemically known as benzoic acid, 4-amino-2-butoxy-, 2-(diethylamino)ethyl ester but generally known as ambucaine, which bears US NIH Compound Identifier 8387. European Medicines Agency schedules Ambucaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05399MIG. The term AMBUCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). AMBUCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ambucaine under HS 29225000 and SITC 51467. As of Q4 2014, AMBUCAINE remains the US FDA Preferred Term for this commodity. Ambucaine bears US NLM identifiers UMLS ID C2346730 and NCI Concept Code C72165. SMILES: O(CCN(CC)CC)C(=O)C1C(OCCCC)CC(N)CC1.